Albert Muñoz‐Vendrell

494 total citations
14 papers, 103 citations indexed

About

Albert Muñoz‐Vendrell is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Albert Muñoz‐Vendrell has authored 14 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 6 papers in Psychiatry and Mental health and 3 papers in Neurology. Recurrent topics in Albert Muñoz‐Vendrell's work include Multiple Sclerosis Research Studies (7 papers), Trigeminal Neuralgia and Treatments (4 papers) and Epilepsy research and treatment (3 papers). Albert Muñoz‐Vendrell is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Trigeminal Neuralgia and Treatments (4 papers) and Epilepsy research and treatment (3 papers). Albert Muñoz‐Vendrell collaborates with scholars based in Spain and United States. Albert Muñoz‐Vendrell's co-authors include Sergio Martínez‐Yélamos, Lucía Romero, Laura Bau, Elisabet Matas, Antonio Martı́nez-Yélamos, Cristina Masuet‐Aumatell, Mariano Huerta Villanueva, Pablo Arroyo, Pol Andrés‐Benito and Joan Prat and has published in prestigious journals such as Frontiers in Immunology, Journal of Neurology and Headache The Journal of Head and Face Pain.

In The Last Decade

Albert Muñoz‐Vendrell

11 papers receiving 99 citations

Peers

Albert Muñoz‐Vendrell

PFM

NEURO

PMH

RHEUM

Marzia Fronza Italy

Vinícius Boldrini Brazil

Siân Price United Kingdom

Svetlana Miletić Drakulić Serbia

Luisa Grazian Italy

Tiziana Tassinari Italy

Gioacchino Tedeschi Italy

Leila Husseini Germany

G Savettieri Italy

Breffni Keegan Italy

Marzia Fronza Italy

Albert Muñoz‐Vendrell

77 ×1.0

PFM

28 ×0.8

NEURO

11 ×0.4

PMH

14 ×1.0

RHEUM

24 ×2.0

Citations per year, relative to Albert Muñoz‐Vendrell Albert Muñoz‐Vendrell (= 1×) peers Marzia Fronza

Countries citing papers authored by Albert Muñoz‐Vendrell

Since Specialization

Citations

This map shows the geographic impact of Albert Muñoz‐Vendrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Muñoz‐Vendrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Muñoz‐Vendrell more than expected).

Fields of papers citing papers by Albert Muñoz‐Vendrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Muñoz‐Vendrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Muñoz‐Vendrell. The network helps show where Albert Muñoz‐Vendrell may publish in the future.

Co-authorship network of co-authors of Albert Muñoz‐Vendrell

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Muñoz‐Vendrell. A scholar is included among the top collaborators of Albert Muñoz‐Vendrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Muñoz‐Vendrell. Albert Muñoz‐Vendrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Matas, Elisabet, Laura Bau, Lucía Romero, et al.. (2025). Benign multiple sclerosis and long-term outcomes after 30 years. Journal of Neurology. 272(11). 747–747.

Naval‐Baudin, Pablo, Antonio Martı́nez-Yélamos, Albert Muñoz‐Vendrell, et al.. (2025). The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis. Multiple Sclerosis and Related Disorders. 103. 106658–106658. 3 indexed citations

Muñoz‐Vendrell, Albert, et al.. (2025). Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen. Headache The Journal of Head and Face Pain. 65(7). 1116–1123. 1 indexed citations

Muñoz‐Vendrell, Albert, et al.. (2025). False nonresponders to anti‐calcitonin gene‐related peptide monoclonal antibodies: A real‐world analysis beyond migraine frequency reduction. Headache The Journal of Head and Face Pain. 66(1). 172–182.

Muñoz‐Vendrell, Albert, A. López-Bravo, Almudena Layos-Romero, et al.. (2025). Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review. Pain Management. 15(3). 161–171. 2 indexed citations

Bau, Laura, Elisabet Matas, Lucía Romero, et al.. (2024). Assessment of the Multiple Sclerosis Severity Score and the Age-Related Multiple Sclerosis Severity Score as health indicators in a population-based cohort. Neurological Sciences. 46(1). 335–342. 2 indexed citations

García‐Azorín, David, et al.. (2024). Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations. Neurological Sciences. 45(9). 4437–4444.

Muñoz‐Vendrell, Albert, et al.. (2023). Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases. Headache The Journal of Head and Face Pain. 63(4). 559–564. 7 indexed citations

Morandeira, Francisco, Albert Muñoz‐Vendrell, Elisabet Matas, et al.. (2023). Kappa free light chains index in multiple sclerosis very long-term prognosis. Frontiers in Immunology. 14. 1223514–1223514. 7 indexed citations

10.

Muñoz‐Vendrell, Albert, Laura Bau, Elisabet Matas, et al.. (2023). Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort. Journal of Neurology. 271(4). 1599–1609. 19 indexed citations

11.

Muñoz‐Vendrell, Albert, et al.. (2022). Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases. Cephalalgia. 42(10). 1031–1038. 17 indexed citations

12.

Muñoz‐Vendrell, Albert, Laura Bau, Elisabet Matas, et al.. (2022). Influence of Cardiovascular Risk Factors in Early Relapsing-Remitting Multiple Sclerosis: A Retrospective Analysis. European Neurology. 86(1). 73–77. 2 indexed citations

13.

Romero, Lucía, Laura Bau, Elisabet Matas, et al.. (2022). The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades. Multiple Sclerosis and Related Disorders. 68. 104103–104103. 41 indexed citations

14.

Muñoz‐Vendrell, Albert, et al.. (2021). Functional neuroimaging in nonepileptiform electroencephalographic patterns in status epilepticus. Acta Neurologica Scandinavica. 144(6). 687–694. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact